GGSK Read More GSK Eyes AnaptysBio (ANAB) Acquisition to Secure Drug ControlAugust 17, 2026 Greenhaven Road Capital, an investment management company, released its second-quarter 2026 investor letter. A copy of the letter…
GGSK Read More GSK unit wins partial dismissal in dostarlimab licence dispute with AnaptysBioMay 20, 2026 GSK unit wins partial dismissal in dostarlimab licence dispute with AnaptysBio Proactive uses images sourced from Shutterstock GSK…